MedTrace Logo

AI-Augmented Skin Cancer Diagnosis in Teledermatoscopy

NCT06080711 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2023-10-12

No results posted yet for this study

Summary

In this study an artificial intelligence (AI) tool for skin cancer diagnosis is implemented in a teleldermatoscopy platform. The aim is to study the effects on clinician diagnostic accuracy, management decisions, and confidence. Furthermore, this prospective randomized study investigates the role of human factors in determining clinician reliance on AI tools and the consequent accuracy in a real-world setting.

Conditions

Interventions

OTHER

AI assistance

Participants will be informed of the diagnostic probabilities for each of ten differential diagnoses according to the AI tool

Sponsors & Collaborators

  • Karolinska Institutet

    collaborator OTHER

  • Medical University of Vienna

    collaborator OTHER

  • Stockholm School of Economics

    collaborator UNKNOWN

  • Karolinska University Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-02-15
Primary Completion
2024-06-30
Completion
2024-10-30

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06080711 on ClinicalTrials.gov